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BACKGROUND: Recent studies show that transfusing
older blood may lead to increased mortality. This raises
the issue of whether transfusing fresher blood can be
achieved without jeopardizing blood availability.
STUDY DESIGN AND METHODS: We propose a
simple family of policies that is defined by a single
threshold: rather than transfusing the oldest available
blood that is younger than 42 days, we transfuse the
oldest blood that is younger than the threshold, and if
there is no blood younger than the threshold then we
transfuse the youngest blood that is older than the
threshold. To assess this policy, we build a simulation
model using data from Stanford University Medical
Center. We focus on the tradeoff between the mean
age of transfused blood and the fraction of transfused
blood that is imported.
RESULTS: For hospitals in which the local supply is
greater than demand, our policy with a threshold of 14
days leads to a decrease of 10 to 20 days in the mean
age of transfused blood while increasing the fraction of
imported blood to less than 0.005 (i.e., 0.5%). If the
health benefits from transfusing fresher blood can be
confirmed by randomized clinical trials, then conserva-
tive assumptions suggest that this policy could reduce
the annual number of transfused patients who die within
1 year by 20,000.
CONCLUSION: The proposed allocation policy with a
threshold of 14 days could allow many US hospitals to
significantly reduce the age of transfused blood, thereby
possibly reducing morbidity and mortality, while having
a negligible impact on supply chain operations.
T
he allocation of available red blood cells (RBCs)
for transfusion to patients is a difficult problem:
compatibility between donor and recipient
must be maintained, and the age and quantity
of available RBCs need to be accounted for. More specifi-
cally, while there is a tendency to use older available blood
to prevent outdating, stored RBCs undergo biochemical
changes that impact RBC function, and the age of trans-
fused blood has been reported to be associated with an
increased risk of infection, postoperative complications,
and/or short-term and long-term mortality.1-6 However,
other results have not confirmed this association, and a
recent review of 24 studies concluded that it is difficult to
determine if there is an association, except possibly in
trauma patients.7 In contrast to similar resource allocation
problems for organ transplants, there is not a centrally
administered or widely accepted allocation policy for RBC
transfusions, nor are there many detailed studies that
propose or assess allocation strategies.8
The aim of our study was to assess whether there is an
RBC allocation policy that can increase the health benefits
(via transfusing fresher blood) without straining the blood
supply, in the event that the results in the studies by Koch
and colleagues,1 Zallen and colleagues,2 Mynster and
Nielsen,3 Offner and colleagues,4 Leal-Noval and col-
leagues,5 and Purdy and colleagues6 can be confirmed by
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randomized clinical trials. We constructed a simulation
modelbasedondata from18,915nonirradiatedRBC trans-
fusions over a 1-year period at the Stanford University
Medical Center (SUMC).While there are exceptions due to,
for example, neonatal surgeries, thenominalpolicyusedat
SUMC is first in, first out (FIFO) among RBCs that are an
exact match (i.e., among the eight blood types) and then
FIFO among all compatible blood types if there are no
RBCs that are an exact match.We introduce a novel family
of allocation policies, which is indexed by a single variable
and which includes SUMC’s nominal policy as a special
case. Our simulation model is used to assess this family of
policies in terms of the tradeoff between blood availability
and the age of transfused blood.
MATERIALS AND METHODS
The key tradeoff
The output of our simulationmodel quantifies the tradeoff
between two performance measures. To motivate the first
of our two performance measures, we performed some
simple accounting (Fig. 1) that led to an equation for the
conservation of blood. Locally (i.e., at the community
blood center) donated units are either transfused or out-
dated (i.e., discarded ifnot transfusedbefore theexpiration
date). Although all demanded transfusions are performed
in our simulationmodel (canceled surgeries due to lack of
RBCs are exceedingly rare in practice, with fewer than 500
nationwide in 2006,9 and SUMC has not canceled or
delayed a surgery in years due to lack of blood), if compat-
ible blood for a transfusion is not locally available then
blood is imported inour simulationmodel. Inpractice, this
bloodwouldbeobtained from, forexample, another-than-
usual blood bank or the National Blood Exchange,10
although our simulation model, as explained below, does
not specify the origin of the imported blood. Because there
are no canceled surgeries, the amount of outdated blood
equals the amount of locally donated blood plus the
amount of imported blood, minus the total amount of
transfusedblood; this equationdescribes the conservation
of RBCs, and Fig. 1 provides the actual values of these
quantitiesovera1-yearperiodatSUMC.Asexplained later,
the amount of locally donated blood and the amount of
transfusedbloodover any timeperiod (e.g., 1 day or 1 year)
are random variables that are not under direct managerial
control in ourmodel. It follows that, for any given amounts
of locally donated blood and transfused blood over any
time period, minimizing the amount of imported blood
over that time period is equivalent to minimizing the
amount of outdated blood over that time period; that is, if
we minimize the amount of imported blood over 1 year
then we automatically also minimize the amount of out-
dated blood over 1 year and vice versa. Hence, we need to
consider only one of these two performance measures
in our tradeoff analysis, and we choose the amount of
imported blood because its cost is more quantifiable
(indeed, the outdate cost is essentially sunk). The other
performancemeasure inourkey tradeoff is themeanageof
transfused blood, and our goal is to simultaneously mini-
mize both performance measures (i.e., the mean import
rate and the mean age of transfused blood). Because the
blood allocation policy can reduce one of these measures
only at the expense of increasing the other, we investigate
this problem with the use of tradeoff curves, as explained
below.
Family of allocation policies
We introduce a new family of allocation policies that is
simple to use, allows for varying importance to be placed
on the age of transfused blood, and never discards blood
before it is outdated. These policies will be tested in the
simulation model that is described later. This family of
policies is characterized by a single threshold, which is
Fig. 1. Supply and demand for units of RBCs at SUMC during April 1, 2008, to March 31, 2009.
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measured in days; all blood in our model takes 2 days to
test and process before being available for transfusion,
and outdates at 42 days of age, and so the threshold is a
managerial variable that takes on an integer value
between 2 and 42. When a patient with a certain blood
type (i.e., O+, O-, A+, A-, B+, B-, AB+, or AB-) requires a
transfusion of 1 unit of blood in our model, he goes
through the following four-step procedure to determine
what type of blood he or she will receive: 1) if there are
RBCs that are an exact match and are younger than the
threshold, then he or she receives the oldest unit younger
than the threshold; 2) otherwise, if there are RBCs that are
an exact match and are older than the threshold, then he
or she receives the youngest unit older than the threshold;
3) otherwise, if there are RBCs of any compatible blood
type (e.g., if the patient is type A+ then he or she could
receive type O+, O-, or A-) that are younger than the
threshold, then he or she receives the oldest (over all com-
patible types) of these RBCs; 4) otherwise, if there are
RBCs of any compatible blood type that are older than the
threshold, then he receives the youngest (over all compat-
ible types) of these RBCs. If the patient does not receive
any RBCs from this four-step procedure then there are no
exact or compatible units available from local donations,
and this transfusion requires imported blood. Note that
setting the threshold equal to 2 or 42 days corresponds to
the last in, first out (LIFO) and FIFO policies (within exact
and compatible matches), respectively. Referring back to
our performance measures, by varying the threshold from
2 to 42 days, we sweep out a tradeoff curve of themean age
of transfused blood versus the fraction of transfused blood
that is imported. A variant of this policy that applies to
only a known subset of patients (e.g., cardiac patients) is
considered (and discussed in detail) under Results.
Simulation model
We develop a simulation model of a queuing system in
which locally donated units of RBCs arrive to the queue,
wait for service, and leave the queue at the end of service.
The server in this queuing system transfuses blood into
patients. More specifically, a service completion occurs at
the time that a unit of RBCs is transfused into a patient,
and a service time in the simulationmodel corresponds to
the time between consecutive units of blood that need to
be transfused. RBCs reaching the age of 42 days before
completing service leave the queue due to outdating. If, at
the end of a service, the four-step procedure does not
generate an allocation (i.e., there was no exact or compat-
ible blood in the queue), then the service is recorded as
using 1 unit of imported blood.The simulationmodel only
tallies the amount of imported blood and does not explic-
itly track the origin, type, or age of imported blood. Hence,
the mean age of transfused blood is calculated using only
the transfusions from local donations. It is possible that
imported blood might be slightly older, on average, than
locally donated blood, at the time of transfusion (e.g., if
blood is obtained from the National Blood Exchange,
which in turn receives blood just before it outdates).
However, the import rate is sufficiently low that this omis-
sion does not affect our qualitative results.
With the allocation policy described earlier, the
model is fully specified by the exact timing of each dona-
tion and each transfusion and the blood type of each
donation and each patient. We first describe the mix of
blood types and then the timing. When a donated unit
arrives to the queue, it is randomly assigned a blood type
according to probabilities calculated from 18,752 nonirra-
diated units transfused at SUMC during April 2008 to
March 2009 (Table 1). Although we do not know the blood
types of all donated (as opposed to all transfused) units at
SUMC, the blood type probabilities in Table 1 should be
very close to the true blood type probabilities among all
donated units because (as shown below) the outdate rate
at SUMC was very small. Blood types for the recipients of
these transfusions were not available. Consequently,
when a unit of blood is transfused in our simulation
model, the blood type of the patient receiving the trans-
fused unit is randomly assigned according to probabilities
calculated from 26,053 patients receiving (irradiated or
nonirradiated) RBC transfusions at SUMC during July 1,
2007, to June 30, 2008 (Table 1). However, the bias due to
irradiation occurs on the donor side; for example, SUMC
tends to irradiatemore groupOblood for neonatal cardiac
surgeries. Blood type mix for patients should also be rep-
resentative of the blood type mix for patients receiving
only nonirradiated blood, as long as, for example, the neo-
natal blood typemix does not differ substantially from the
adult blood type mix.
The timing of the actual donations and transfusions at
SUMC during April 2008 to March 2009 exhibits several
complexities: predictable seasonality with weekly and
annual cycles,multiple units of RBCs being donated by the
same donor or transfused into the same patient on the
same day, and statistical dependence between the donor
and transfusion processes (e.g., expedited blood drives
when RBC inventory is low). To allow for the flexibility to
extrapolate beyond the specific SUMC setting (e.g., by
TABLE 1. Mix of blood types for donated units
and patients
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varying the supply-to-demand ratio) while mimicking the
impact of these realistic aspects of the SUMC system, we
assume that the arrival process of donated units and the
service process of transfused units are independent
renewal processes (i.e., the time between consecutive
events are independent and identically distributed
random variables11), each having the same coefficient of
variation (CV), which is the standard deviation divided by
the mean, of the time between consecutive events (i.e.,
donations or transfusions, respectively). Queuing theory
suggests that the key performance measures can be accu-
rately and succinctly derived from themeandonation rate,
the mean transfusion rate, and the CV (Sections 9.6, 9.9,
and 10.2 inWhitt11). That is, the CV is a surrogate measure
that accounts for the complexities mentioned above.
We calculate the CV, which is an input to our model,
from data related to two performance measures at SUMC:
the fraction of transfused units that were imported and
the fraction of donated blood that was outdated.The Stan-
ford Blood Center’s estimate of the import rate during
April 2008 toMarch 2009was between 0.005 and 0.015, but
they lacked explicit data to derive a more precise value.
Consequently, we assume that a unit was imported during
April 2008 to March 2009 if it was transfused on the same
day it was delivered to the hospital, which yields an import
rate of 215/18,915 = 0.0114. Because this estimate is very
crude, we consider a wide range of import rates (indeed,
much wider than 0.005-0.015) in the sensitivity analyses.
We have outdate data for SUMC only during July 2009 to
June 2010, and we assume that the number of outdates
during this time period is the same as during our time
period of interest. Outdates can occur at either the SUMC
or the Stanford Blood Center; we include the outdates at
the Stanford Blood Center because SUMC is by far their
largest customer. There were 52 units with a shelf life of 42
days that outdated at the blood center during July 2009 to
June 2010. There were an additional 30 units that outdated
at SUMC but we were unable to get information about
their shelf life, and we did not include these 30 units
because 94% of the outdates at the Stanford Blood Center
had shelf lives of less than 42 days (due to irradiation).
Thus, we estimate the outdate rate at SUMC to be
52/18,752 = 0.0028. Note that 18,752 = 18,915 - 215 + 52
because the RBCs for the transfusions requiring imported
blood were not from local donations, but from elsewhere
(Fig. 1). Consequently, the donation rate is 18,752/
365 = 51.38/day and the transfusion rate is 18,915/
365 = 51.82/day. We refer to the donation rate as the
supply and the transfusion rate as the demand, giving a
supply-to-demand ratio of 18,752/18,915 = 0.9914. We
simulate the queuing system to find the value of the CV
that minimizes the sum of the squared deviations
between the exact and simulated import rate plus the
exact and simulated outdate rate. This approach yields a
CV of 1.32 (resulting in an import rate of 0.0108 and an
outdate rate of 0.0037), which is slightly larger than the
canonical value of 1.0 that corresponds to the case in
which donations and transfusions are independent
Poisson processes. Recall that the supply-to-demand ratio
of 0.9914 is a ratio of annual rates; in our simulation
model, the daily ratio of donated units divided by trans-
fused units will vary considerably due to the large amount
of statistical uncertainty.
In summary, the timing and blood type of each
donated unit and each transfused unit are random in the
simulation model and do not correspond in a one-to-one
manner to the timing and blood type of each donated unit
and each transfused unit at SUMC during April 2008 to
March 2009. However, the input variables of the simula-
tion model (donor rate, transfusion rate, blood type mixes
in Table 1, and CV) are chosen so that the aggregate
output measures of the model (e.g., outdate rate, import
rate) are roughly consistent with the aggregate perfor-
mance measures experienced at SUMC. In particular, the
high value of the CV leads to significant day-to-day varia-
tion in the number of donations and transfusions.
RESULTS
Main results
The tradeoff curves are generated by increasing the
threshold from 2 to 42 days, with 42 corresponding to the
upper left point on each curve and 2 corresponding to
the lower right point (Fig. 2). The nature of the tradeoff
between the mean age and the import rate of transfused
blood is highly dependent on the supply-to-demand ratio
(Fig. 2). When the supply-to-demand ratio is less than or
equal to 0.98, the tradeoff curve is nearly horizontal (on
the linear scale) and the mean age of transfused blood is
only several days, regardless of the value of the threshold.
In contrast, when the supply-to-demand ratio is greater
than or equal to 1.06, the tradeoff curve is almost vertical
and barely any imports occur, irrespective of the value of
the threshold. In the latter case, the status quo policy (i.e.,
the threshold equals 42 days) leads to a mean age of
approximately 35 days when the supply-to-demand ratio
is between 1.04 and 1.10.
Sensitivity analyses
We assess the robustness of our results with respect to two
variables: the amount of variability in the system (as
measured by the CV of the arrival and service processes)
and the size of the hospital (as measured by the donation
rate and transfusion rate). We also consider a change in
the blood type mix of donations and recipients.
Recall that the CV was derived from our estimates of
the SUMC import rate and outdate rate, both of which
may be inaccurate. Before showing the results of the sen-
sitivity analysis of the CV, we consider how much the CV
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would change if we changed our esti-
mates of the SUMC import rate or
outdate rate. Changing the import rate
from 0.0114 to 0.002 or 0.05 changes the
CV (via least squares, as described
underMaterials andMethods) from1.32
to approximately 0 and 2.28, respec-
tively. The simulation did not fit the
data well when both the import rate and
the outdate rate were less than 0.003.
Changing the outdate rate from 0.0028
to its upper bound of 82/18,752 by
including the 30 units outdated at the
Stanford Blood Center, yields a CV of
1.55. Consequently, we choose to vary
the CV between 0.01 and 2.64 (i.e.,
double the base value) in our sensitivity
analysis, which comfortably subsumes
these changes in the import rate and
outdate rate.
Analogs of Fig. 2 when the CV
equals 0.01 and 2.64 (rather than the
base case of 1.32) show that the tradeoff
curves shift slightly to the left when the
CV is 0.01 and slightly to the right when
the CV is 2.64 (data not shown). Simi-
larly, multiplying the donation and
transfusion rates by 0.5 shifts the
tradeoff curves slightly to the right, and
multiplying the rates by 1.5 shifts the
curves slightly to the left (data not
shown). Overall, our qualitative conclu-
sions are unaffected by large changes in
the amount of variability or the size of
hospitals.
Finally, because we do not have
precise blood type data for the patients
at SUMC during April 2008 to March
2009, we recompute Fig. 2 under two
different assumptions to examine how
sensitive our results are to the blood
type distributions of recipients and
donations. Both of these scenarios use
distributions that are likely to be farther
from the true values for recipients or
donations during April 2008 to March
2009 than the values used in our base-
case analysis (Table 1). First, we assume
that the blood type probabilities for
patients (the last column of Table 1) are
replaced by the blood type mix of
donated units in Table 1. Second, we
replace the blood type probabilities for
donations by the blood type probabili-
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Fig. 2. The tradeoff curve for various values of the supply-to-demand ratio, with the
import rate on a (A) logarithmic and (B) linear scale. The four tick marks on each
curve correspond to threshold values of 2, 14, 28, and 42 days. Because 500,000
transfusions were simulated to generate each point on these curves, we are not able
to accurately estimate import rates of less than 10-5.
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ford Blood Center during July 2009 to June 2010, which are
0.4037, 0.0918, 0.2797, 0.0624, 0.0995, 0.0192, 0.0354, and
0.0083. This mix differs from the mix of donated units in
Table 1 because it includes both irradiated and nonirradi-
ated units and includes units shipped to hospitals other
than SUMC.
System performance degrades when the patient and
donation distributions are the same, with the import rate
nearly an order of magnitude larger than the base case in
some instances (data not shown). However, when we use
the donation mix from Stanford Blood Center during July
2009 to June 2010, the performance exceeds that of the
base case and there are no imports for a supply-to-
demand ratio greater than 1.02. Nonetheless, the qualita-
tive behavior from Fig. 2B is maintained in both cases,
with the tradeoff curves transitioning from horizontal to
vertical as the supply-to-demand ratio increases. The dis-
crepancy in performance is due to the fact that the system
can more flexibly satisfy demand when the proportion of
blood that is D- is larger among donations than among
patients. Our three scenarios vary significantly in this
regard: 15% of donations and only 9% of patients have D-
blood in the base case (Table 1), and 18% of donations to
the Stanford Blood Center during July 2009 to June 2010
were D-. Therefore, consideration should be given to the
proportion of D- blood among donations and patients,
which may vary geographically, when determining an
appropriate threshold.
An illustrative assessment of costs and
health benefits
Although there is essentially no tradeoff between our two
performance measures when the supply-to-demand ratio
is 1.06 or greater, there is a tradeoff between costs and
benefits when this ratio is less than 1.06. For illustrative
purposes, the quantification of this tradeoff is calculated
using the tradeoff curve corresponding to a supply-to-
demand ratio of 1.01 in Fig. 2 and a retrospective study on
the impact of long storage times on 1-year death rates;1
the veracity of the results in the study by Koch and col-
leagues1 is addressed under Discussion. The points
(0.0008,18.5) and (0.005,6.5) on the curve in Fig. 2, which
are generated by threshold values of 42 and 14 days,
respectively, imply that an increase in the fraction of
imported blood by 0.0042 corresponds to a reduction in
the mean age of transfused blood of 12 days. Koch and
colleagues1 observed an association for the 1-year death
rate of 7.4% for 2872 cardiac patients receiving blood
stored for 14 days or less (median, 11 days) and 11.0% for
3130 cardiac patients receiving blood older than 14 days
(median, 20 days).1 To obtain a rough estimate, we make
two simplifying assumptions: we equate the mortality
reduction due to the difference in mean age between 6.5
and 18.5 days for the two points on our curve to the mor-
tality reduction due to the difference in median age
between 11 and 20 days in the study by Koch and col-
leagues1 and we conservatively assume that the benefits
from fresher blood apply only to 27% of the transfused
population (27% of transfused units at SUMC were for
cardiac patients,8 and the mean number of transfused
units for cardiac patients and the general population are
similar: 3.261 and 3.0,9 respectively). These two assump-
tions yield that the reduction in the 1-year death probabil-
ity generated by an increase of 0.0042 in the fraction of
imported blood is 0.27 (0.11 - 0.074) = 0.01. The cost asso-
ciated with imported blood equals the typical cost of
blood collection, production, and distribution (approx.
$200/unit12) plus the additional cost to buy and transport
blood from a nonlocal source (approx. $50-$100/unit,
depending on the market value, the time of year, and
whether there is a surplus of blood). At 3 units of blood
per patient,9 the expected cost per transfused patient
to reduce the 1-year death probability by 0.01 is 3
(0.005 - 0.0008) $300 = $3.78. However, we must temper
this argument slightly because the imported blood is likely
to be older and would possibly be associated with an
adverse outcome. Finally, if we wanted to focus on serious
adverse events (as defined by the Society of Thoracic Sur-
geons) rather than 1-year mortality, using the two end-
points in Fig. 2 of Koch and colleagues1 yields a reduction
in the serious adverse event probability (due to an
increase in the fraction of imported blood of 0.0042) of
(0.27) (12 days) (0.34 - 0.16)/(42 days) = 0.0139.
We can perform similar calculations—again using the
results in the study by Koch and colleagues1—to obtain
rough estimates for the total health benefits achievable by
the proposed policy. The number of patients receiving
transfusions was 14.461 ¥ 106 units/3.0 units/patient in
2006.9 We assume that health benefits from fresher blood
are received only by cardiac patients (27% of total) who
receive nonirradiated blood (92% of total, Whitaker et al.,
p. 289), because we only study nonirradiated transfusions.
Recalling that the nationwide supply-to-demand ratio is
1.085, we conservatively assume that only half of the
nation’s hospitals employ our policy, that these hospitals
have a supply-to-demand ratio of 1.04, and that they use a
threshold of 14 days rather than 42 days, thereby reducing
the mean age of blood by 23.8 days, from 33.4 days to 9.6
days (Fig. 2). The proposed policy would then reduce the
annual number of adverse events by (14.461 ¥ 106/3.0)
(0.92) (0.27) (0.5) (23.8 days) (0.34 - 0.16)/(42 days) =
61,066. Conservatively assuming that the percentage
reduction in 1-year death probability generated by a dif-
ference in mean age between 9.6 and 33.4 days in Fig. 2 is
the same as the reduction generated by a difference in
median age between 11 and 20 days in the study by Koch
and colleagues,1 the proposed policy reduces the annual
number of patients who die within 1 year of transfusion by
(14.461 ¥ 106/3.0) (0.92) (0.27) (0.5) (0.11 - 0.074) = 21,552.
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Targeting a known subset
of patients
Improvements inmortality andmorbid-
ity from receiving fresh blood have
mainly focused on special subsets of
patients, such as trauma patients7 or
those undergoing cardiac surgery.1
Therefore, we next examine the case in
which the threshold policy applies to
only a certain segment of the patient
population (referred to as Type I
patients). That is, we modify our policy
so that Type I patients continue to use
the proposed policy with a discretionary
threshold, but the remaining (i.e., Type
II) patients use a threshold of 42 days,
which corresponds to using the oldest
available exact match or the oldest
available compatible match if no exact
match is available. For concreteness, we
define Type I patients to be cardiac
patients. Based on data during April
2008 to March 2009, 27% of transfused
units at SUMC are for cardiac surgery.8
Therefore, in our simulation model 27%
of the transfused units are randomly
assigned to be Type I and the remaining
73% are defined to be Type II.
As we vary the threshold for Type I
patients, we sweep out two tradeoff
curves: one for Type I patients and one
for Type II patients (Fig. 3). A compari-
son of Fig. 2 (which corresponds to
100% of patients being Type I) and Fig. 3
allows for several observations. As
expected, when Type I patients use a
threshold of 42 days, both curves coin-
cide in Fig. 3 (i.e., they intersect at the
upper left part of these curves, which is
also the same as the upper left point of
the curves in Fig. 2). The import rates
in Fig. 3 are nonzero for supply-to-
demand ratios less than or equal to 1.02
and are less than the corresponding
import rates in Fig. 2, which is not
surprising given that in Fig. 2 the import
rates are nonzero for supply-to-demand
ratios up to 1.10 for patients with discre-
tionary thresholds, but are nonzero only
up to a ratio of 1.02 for patients with a
threshold of 42 days (which comprises
73% of the transfused units in Fig. 3).
The tradeoff curves for Type I patients in
Fig. 3 dominate (i.e., lie to the southwest






































































Fig. 3. Two tradeoff curves (a solid curve for the Type I patients that have a discre-
tionary threshold and a dashed curve for the Type II patients that have a threshold
of 42 days) for various values of the supply-to-demand ratio, with the import rate on
a (A) logarithmic and (B) linear scale. The four tick marks on each curve correspond
to threshold values (for the Type I patients with a discretionary threshold) of 2, 14,
28, and 42 days. Because 500,000 transfusions were simulated to generate each point
on these curves, we are not able to accurately estimate import rates of less than 10-5.
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of) the original tradeoff curves in Fig. 2, but this is at the
expense ofType II patients; indeed, the weightedmeans of
the dashed and solid curves in Fig. 3 are dominated by the
tradeoff curves in Fig. 2 for positive import rates. For
supply-to-demand ratios of 1.02 or greater, there is a large
difference in the mean age of transfused blood for the two
types of patients (e.g., at a ratio of 1.04 and a threshold of
14 days, the mean age is 12 days for Type I patients and 31
days for Type II patients). The tradeoff curves for Type II
patients are not always monotonic: at small supply-to-
demand ratios, as the threshold rises from small values,
Type I patients will receive relatively older blood, which
gives Type II patients an opportunity to receive fresher
blood.
DISCUSSION
Many physical13 and biologic14 systems undergo phase
transitions, where system behavior changes dramatically
as a key variable exceeds a certain level, and queuing
models are no exception: their behavior depends greatly
on whether supply is greater than, or less than, demand
(Fig. 2). The nationwide supply-to-demand ratio of whole
blood and RBCs was 15.688 ¥ 106/14.461 ¥ 106 = 1.085 in
2006.9 Due to the difficulty in predicting supply (e.g., yield
from a blood drive) and demand at the local level and the
desire to hedge against shortages, it is optimal (based on
standard results from inventory theory15) to hold a small
amount of safety stock in excess of forecasted demand and
hence to target a supply-to-demand ratio above 1.0.
However, friction in themarketplace (e.g., the high relative
cost of transporting blood long distances, limited power of
small hospitals in their supply chains), and geographical
variation in supply and demand cause the supply-to-
demand ratio to vary significantly across hospitals and
years, from below 1.0 (e.g., it was 0.9914 at SUHC in 2007-
2008) to well above 1.0.
Consequently, many hospitals operate on each side of
the phase transition, and rather than having a consistent
nationwide allocation policy, a considerable reduction in
the age of transfused blood can be achieved by having an
allocation policy that varies according to whether supply
is greater than, or less than, demand. More specifically,
when supply is less than demand, it is not possible to
significantly alter the age of transfused blood (see Fig. 2,
where fresh blood is transfused regardless of the value of
the threshold), and the status quo policy of allocating the
oldest available blood (i.e., using a threshold of 42 days)
should remain in use. However, when supply is greater
than demand, which presumably is the state of affairs at
the majority of hospitals, it is very unlikely that imports
will occur due to unavailable local blood, and conse-
quently the amount of outdated blood is not under mana-
gerial control (aside from the caveat that local surplus can
be salvaged on the National Blood Exchange in the days
before expiration) and is equal to the supply minus the
demand (e.g., in 2006, nationwide supply minus demand
was 15.688 ¥ 106 - 14.461 ¥ 106 = 1.227 ¥ 106 and the
actual number of outdated units was 1.276 ¥ 106,9 but
some hospitals had supply less than demand). That is, if
supply is greater than demand, then outdates are
unavoidable. Hence, if a reduction in the age of transfused
blood is deemed to be beneficial (more on this below),
then when supply is greater than demand, a cultural shift
would be needed among systemmanagers, where the tra-
ditional emphasis on minimizing outdates needs to be
replaced by an emphasis on transfusing fresher blood. Our
results suggest that a very simple policy, using a threshold
of 14 days, can significantly reduce the age of transfused
blood while having a minimal impact on the amount of
imported blood (Fig. 2). This approach can be used not
only across hospitals, but also across the time of year
within a hospital, for example, using the status quo policy
during the summer months and winter holidays when
supply is low and using lower thresholds during the
remainder of the year.
The above argument relies on the assumption that—
when supply is greater than demand—the benefits from a
reduction in the age of transfused blood outweigh the
costs of additional imported blood. Although there is
essentially no tradeoff when the supply-to-demand ratio
is 1.06 or greater, there is a tradeoff when the supply-to-
demand ratio is less than 1.06. For illustrative purposes,
the quantification of this tradeoff was calculated using a
retrospective study on the impact of large storage times on
1-year death rates.1 However, the health impacts reported
by Koch and colleagues1 are larger than those in most
other studies that also found benefits from fresher blood2-6
and Koch and colleagues1 have come under criticism.16
Moreover, a review of 24 studies—many of which were
observational cohort studies—found contrasting evi-
dence, with some studies generating no impact on out-
comes from the age of transfused blood.7 Hence, until the
results of Koch and colleagues1 can be confirmed by ran-
domized clinical trials, they should be viewed as an upper
bound on the impact of blood age on health outcomes.
However, our tradeoff calculations are conservative in
every other way (i.e., aside from the use of the results in
Koch et al.1), and our tradeoff results—if the benefits
reported by Koch and colleagues1 can be confirmed—are
striking: $3.78 per transfused patient to reduce the 1-year
death probability by 0.01 and an annual reduction in the
number of patients who die within 1 year of transfusion by
21,552. In any case, ongoing clinical trials may shed more
light on this topic,17 and our calculations provide a basis
for quantifying the costs and benefits associated with a
change from a FIFO-base policy to the proposed policy.
Turning to the targeted policy, a comparison of
Figs. 2 and 3 suggest that if indeed a known class of
patients are sensitive to the age of transfused blood (e.g.,
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27% of transfused units went to cardiac patients in our
calculations, based on SUMC data) and the remaining
patients’ medical outcomes are independent of the age
of transfused blood, then the targeted policy (where Type
I patients have a discretionary threshold and Type II
patients have a threshold of 42 days) outperforms the
untargeted policy in which all patients have the same
threshold. Given the equity issues generated by the tar-
geted policy and the current uncertainty regarding the
clinical impact of receiving different age blood for
various classes of patients, coupled with the obvious
benefits generated by the untargeted policy, we believe
that the untargeted policy is preferable to the targeted
policy. Moreover, one could investigate more compli-
cated policies in which the threshold varies with the
blood types of both the donated blood and the patient.
While this approach may improve the average perfor-
mance (as measured by the tradeoff curves) and could be
used to reduce inequity of the mean age of transfused
blood across the blood types of recipients, the increased
complexity of such a policy makes it less attractive for
implementation.
Our study has several limitations. Ourmodel captures
some of the complexities in the timing of donations and
transfusions in a succinct but approximate manner. Every
hospital differs on a variety of dimensions—the surgical
volume, the exact mix of blood types for donors and
patients, the supply-to-demand ratio, the mix of proce-
dures it performs, the nature of seasonality, the correla-
tion between demand and replenishment, the details of
their supply chain (e.g., blood centers vs. American Red
Cross, the fraction of their main supplier’s RBCs that a
hospital consumes)—that can affect our main tradeoff
curve, and we have focused on data from a single hospital
in a single year. In addition, our model considers only
nonirradiated RBCs with a shelf life of 42 days (to incor-
porate the approximately 10% of the US blood supply that
is currently irradiated, our model would need to be gen-
eralized to 16 blood types—eight with shelf lives of 42 days
and eight with shorter shelf lives—and a policy with two
thresholds: one for irradiated blood and one for nonirra-
diated blood); ignores the need for cytomegalovirus and
other secondary compatibility considerations; and does
not incorporate crossmatching, pediatric patients, or an
array of rare situations. A few of these factors may cause
the model to underestimate the mean age of transfused
blood and overestimate the impact of the threshold on the
mean age of transfused blood. Nevertheless, our sensitiv-
ity analyses—and a large body of queuing theory implying
that the first-order effect in queuing systems is due solely
to the supply-to-demand ratio11—suggest that our main
result is robust.
In conclusion, when the annual local supply of RBCs
exceeds annual demand, as it does in many US hospitals,
the excess supply will eventually outdate (perhaps at the
community blood centers rather than at the hospitals),
regardless of the allocation policy. In this case, the easy-
to-implement family of allocation policies introduced
here, which provides a continuum of policies between
FIFO and LIFO, has the potential to significantly reduce
themean age of transfused blood, possibly providing con-
siderable health benefits, while having a negligible impact
on blood availability.
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